HRTX
Heron Therapeuti
NASDAQ: HRTX · HEALTHCARE · BIOTECHNOLOGY
$1.19
-1.65% today
Updated 2026-04-29
Market cap
$224.36M
P/E ratio
—
P/S ratio
1.45x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$1 – $3
Volume
2.1M
Heron Therapeuti (HRTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
-0.5%
Most recent quarter
EPS YoY growth
-200.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-8.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-11.3%
2026-03-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-04 | $-0.02 | -33.3% | $1.15 | $1.02 | -11.3% |
| 2025-11-04 | $-0.10 | -900.0% | $1.18 | $1.11 | -5.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.02 | $-0.02 | -33.3% | $40.59M | -0.5% |
| 2025-09-30 | $-0.01 | $-0.10 | -900.0% | $38.21M | +16.5% |
| 2025-06-30 | $-0.01 | $-0.02 | -100.0% | $37.20M | +3.3% |
| 2025-03-31 | $-0.01 | $0.01 | +234.0% | $38.90M | +12.2% |
| 2024-12-31 | $-0.03 | $0.02 | +180.0% | $40.78M | +19.1% |
| 2024-09-30 | $-0.03 | $-0.03 | -5.7% | $32.81M | +4.4% |
| 2024-06-30 | $-0.04 | $-0.06 | -50.0% | $36.02M | +13.4% |
| 2024-03-31 | $-0.09 | $-0.02 | +77.8% | $34.67M | +17.1% |
| 2023-12-31 | $-0.16 | $-0.07 | +56.3% | $34.23M | — |
| 2023-09-30 | $-0.29 | $-0.17 | +41.4% | $31.43M | — |
| 2023-06-30 | $-0.23 | $-0.35 | -52.2% | $31.76M | — |
| 2023-03-31 | $-0.20 | $-0.27 | -35.0% | $29.61M | — |
| 2022-12-31 | $-0.28 | $-0.17 | +39.3% | — | — |
Frequently asked questions
Has Heron Therapeuti beaten earnings estimates?
Heron Therapeuti has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports.
How does HRTX stock react to earnings?
HRTX stock has moved an average of -8.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Heron Therapeuti's revenue growth rate?
Heron Therapeuti reported year-over-year revenue growth of -0.5% in its most recent quarter, with EPS growing -200.0% year-over-year.